Nicolien T van Ravesteyn
Overview
Explore the profile of Nicolien T van Ravesteyn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1837
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Stigt B, Olthof E, de Kok I, Heijnsdijk E, Lansdorp-Vogelaar I, van Ravesteyn N, et al.
Prev Med
. 2025 Mar;
193:108257.
PMID: 40037505
Objective: Population-based screening programs for breast, cervical, and colorectal cancer have been proven effective in detecting cancer at an early or precancerous stage, thereby enabling better patient outcomes. For screening...
2.
Irzaldy A, Otten J, Kregting L, van der Molen D, Verkooijen H, van Ravesteyn N, et al.
Qual Life Res
. 2024 Sep;
34(1):161-171.
PMID: 39287764
Purpose: Breast cancer (BC) screening enables early detection of BC, which may lead to improved quality of life (QoL). We aim to compare QoL between women with a screen-detected and...
3.
Stout N, Miglioretti D, Su Y, Lee C, Abraham L, Alagoz O, et al.
JAMA Intern Med
. 2024 Aug;
184(10):1222-1231.
PMID: 39186304
Importance: Information on long-term benefits and harms of screening with digital breast tomosynthesis (DBT) with or without supplemental breast magnetic resonance imaging (MRI) is needed for clinical and policy discussions,...
4.
Trentham-Dietz A, Hunter Chapman C, Jayasekera J, Lowry K, Heckman-Stoddard B, Hampton J, et al.
JAMA
. 2024 Apr;
331(22):1947-1960.
PMID: 38687505
Importance: The effects of breast cancer incidence changes and advances in screening and treatment on outcomes of different screening strategies are not well known. Objective: To estimate outcomes of various...
5.
Pinto-Carbo M, Vanaclocha-Espi M, Martin-Pozuelo J, Romeo-Cervera P, Hernandez-Garcia M, Ibanez J, et al.
Eur J Public Health
. 2024 Apr;
34(4):806-811.
PMID: 38578614
Background: The recommendation for the implementation of mammography screening in women aged 45-49 and 70-74 is conditional with moderate certainty of the evidence. The aim of this study is to...
6.
Kregting L, Vrancken Peeters N, Clarijs M, Koppert L, Korfage I, van Ravesteyn N
Int J Cancer
. 2024 Mar;
155(1):117-127.
PMID: 38478916
In breast cancer research, utility assumptions are outdated and inconsistent which may affect the results of quality adjusted life year (QALY) calculations and thereby cost-effectiveness analyses (CEAs). Four hundred sixty...
7.
Irzaldy A, Gvamichava R, Beruchashvili T, Sturua L, van Ravesteyn N, de Koning H, et al.
Value Health Reg Issues
. 2023 Nov;
39:66-73.
PMID: 37992568
Objectives: To define the optimal and cost-effective breast cancer screening strategy for Georgia. Methods: We used the Microsimulation Screening Analysis-Breast (MISCAN-Breast) model that has been adapted to the Georgian situation...
8.
Kregting L, van Ravesteyn N, Chootipongchaivat S, Heijnsdijk E, Otten J, Broeders M, et al.
Int J Cancer
. 2023 Apr;
153(2):312-319.
PMID: 37038266
Women tend to make a decision about participation in breast cancer screening and adhere to this for future invitations. Therefore, our study aimed to provide high-quality information on cumulative risks...
9.
Zielonke N, Senore C, Ponti A, Csanadi M, de Koning H, Heijnsdijk E, et al.
J Med Screen
. 2023 Feb;
30(3):134-141.
PMID: 36762395
Objectives: Organized breast cancer screening may not achieve its full potential due to organizational and cultural barriers. In Italy, two identified barriers were low attendance in Southern Italy and, in...
10.
Clarijs M, Kregting L, van Ravesteyn N, Koppert L, Korfage I
Qual Life Res
. 2022 Oct;
32(2):373-381.
PMID: 36264532
Purpose: Normative utility scores represent the health related quality of life of the general population, are of utmost importance in cost-effectiveness studies and should reflect relevant sexes and age groups....